Business

QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro

articleQuidelortho CorporationAugust 28, 20255/company/quidel-corporation/news/quidelortho-participate-baird-2025-global-healthcare-conference-2025-08-28
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

About this update from Quidelortho Corporation

[{"type":"text","content":"SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the \"Company\" or \"QuidelOrtho\"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will participate in the Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025. The Company's fireside chat will begin at 3:10 p.m. ET / 12:10 p.m. PT.\n\n \n \n \n \n \n \n\n \nInterested parties can access the live webcast and replay in the \"Events & Presentations\" section of the \"Investor Relations\" page of QuidelOrtho's website at https://ir.quidelortho.com.\nQuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.\nAbout QuidelOrtho Corporation\nQuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent in vitro diagnostics solutions that transform data into understanding and action for more people in more places every day. \nBy offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, QuidelOrtho brings fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic.\nBuilding on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.\nInvestor Contact:Juliet CunninghamVice President, Investor [email protected] \nMedia Contact:D. Nikki WheelerSenior Director, Corporate [email protected] \n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-participate-in-the-baird-2025-global-healthcare-conference-302540601.html\nSOURCE QuidelOrtho Corporation","length":4171,"tagName":"div"}]

More updates from Quidelortho Corporation